Tech Company Financing Transactions

Source Molecular Funding Round

On 7/14/2017, Source Molecular raised $1.3 million in Series A financing from New World Angels and private investors.

Transaction Overview

Company Name
Announced On
7/14/2017
Transaction Type
Venture Equity
Amount
$1,267,500
Round
Series A
Investors

New World Angels (Jon Cole)

Proceeds Purpose
The Series A funds will be used to develop new product offerings including self-test kits, project modeling software as well as expand global marketing efforts.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
15280 NW 79th Ct. 107
Miami, FL 33016
USA
Email Address
Overview
Source Molecular Corporation is a private commercial laboratory founded in 2002 with a mission to fill the void between source identification research and real-world implementation of the technology.
Profile
Source Molecular LinkedIn Company Profile
Social Media
Source Molecular Company Twitter Account
Company News
Source Molecular News
Facebook
Source Molecular on Facebook
YouTube
Source Molecular on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mauricio Larenas
  Mauricio Larenas LinkedIn Profile  Mauricio Larenas Twitter Account  Mauricio Larenas News  Mauricio Larenas on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/14/2017: ClearServe Holdings venture capital transaction
Next: 7/14/2017: Collective Returns venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary